We’re reimagining diagnostics by

READING THE IMMUNE SYSTEM

of acute infections

PRESENCE

TYPE

SEVERITY

Quickly identifies the

InSep™

BACTERIAL

or

VIRAL

Quickly identifies
infections as

ViraBac™

Inflammatix – Homebiosearchadmin2021-01-14T11:37:06-07:00

Host Response Diagnostics

Delivering precision medicine on demand

Actionable Results

We rapidly measure the patient’s immune response using proprietary algorithms to generate clinically actionable results in less than 30 minutes. Faster diagnosis means smarter antibiotics prescribing and level of care decisions, which enables better patient outcomes.

Clinically Validated

Validated in numerous independent cohorts involving thousands of patients and published in leading medical journals, Inflammatix is your trusted partner for providing state-of-the-art diagnostic solutions.

SEE OUR PIPELINE

TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

InSep Acute Infection & Sepsis Test for Hospitals

Determine the presence, type and severity of infection to make smarter antibiotic prescribing and admission decisions.

CoVerity SARS-CoV-2 Severity Test for Hospitals

Determine which COVID-19 positive patients are at greater risk of a more severe clinical course to make optimal treatment decisions.

ViraBac Acute Infection Test for Clinics

Quickly determine whether infections are likely viral or bacterial to empower appropriate antibiotic usage.

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people

host-response-diagram

In the News: Game Changing Impact

Recent notable news stories

December 15, 2020

A Bright Future Ahead for Novel Markers of Infection

Link to story

October 29, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Link to Story

October 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Link to story

September 30, 2020

Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

Link to story

Also covered by

Stay in touch with social updates: Find out the latest news.

Follow us on Twitter

Follow us on LinkedIn